While initial infection of the virus has resulted in risk of hospitalization and mortality, researchers looked into the effects of reinfection as data has been unclear.
Those who have been reinfected with COVID-19 have an increased risk of experiencing mortality, hospitalization or other serious health conditions compared to the first time being infected, regardless the vaccination status.
While initial infection of the virus has resulted in risk of hospitalization and mortality, researchers looked into the affects of reinfection as data has been unclear.
The information was collected from the U.S. Department of Veterans Affairs’ national healthcare database from March 1, 2020 through April 6, 2022 and recently published as a study in Nature Medicine. The cohort study includes individuals with one COVID-19 infection (443,588 patients), two or more infections (40,947) and no infections (5.3 million). Their symptoms were recorded and monitored roughly up to 6 months after their infection.
It was revealed reinfected patients had a more than doubled risk of death and a more than tripled risk of hospitalization compared with those who were infected with COVID just once. They also had increased risks for problems with lungs, heart, blood, kidneys, diabetes, mental health, bones and muscles, and neurological disorders, the study said.
The risks and burdens of repeat infection increased with the number of infections, the study said.
In addition, reinfected patients were more than likely to develop lung problems, three times more likely to suffer heart conditions and 60% more likely to experience neurological disorders than patients who had been infected only once.
Further investigations are recommended for COVID reinfection as there are limitations to this study, which focused solely on the health risks associated with those individuals who had reinfection.
The study did not look into further popualtions outside of Veterans Affairs which consists of those who are mostly older white males. Outside of that the cohorts included 589,573 women participants, and 12% were roughly under 38-years-old. Subgroup analyses were not conducted by age, sex or race.
Prevention of COVID infection and reinfection is encouraged to be the goal of public health policy because prevention could protect folks from additional health risks.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More